Neoplasias das glândulas salivares minor - Estudo retrospectivo

  • Joana Candeias Deus Hospital Santa Maria
  • Marco Menezes Peres Hospital Prof. Doutor Fernando Fonseca
  • Ana Hebe Instituto Português de Oncologia, Lisboa Francisco Gentil
  • Lígia Ferreira Instituto Português de Oncologia, Lisboa Francisco Gentil
  • Pedro Montalvão Instituto Português de Oncologia, Lisboa Francisco Gentil
  • Miguel Magalhães Instituto Português de Oncologia, Lisboa Francisco Gentil
Palavras-chave: tumores malignos, glândula salivares minor, estudo retrospectivo

Resumo

Objectivos: Análise descritiva dos casos de neoplasias das glândulas salivares minor tratados no serviço de Otorrinolaringologia do IPO de Lisboa, e comparação dos resultados com o que está descrito na literatura.

Metodologia: Análise retrospectiva de todos os casos com diagnóstico histológico de neoplasia das glândulas salivares minor das cavidade nasal, cavidade oral, laringe e faringe, que ocorreram durante o período entre Outubro de 1992 a Novembro de 2015, tratados no serviço de Otorrinolaringologia do Instituto Português de Oncologia de Lisboa, Francisco Gentil.

Resultados : Foram documentados 58 casos de neoplasia das glândulas salivares minor, 60% ocorreram em indivíduos do sexo feminino e 40% ocorreram no sexo masculino, com um média de idades de 57 anos. O sintoma mais frequente na cavidade nasal foi a obstrução nasal, na cavidade oral a presença de úlcera ou tumefacção, e na orofaringe a dor. Os tipos histológicos mais comuns foram o carcinoma adenoide quístico (33%), o adenocarcinoma polimórfico (24%) e o carcinoma mucoepidermóide (22%). A orofaringe foi o local mais comum destas neoplasias. A cirurgia foi o tratamento de 1ª linha em 93% dos casos e 52% realizaram radioterapia adjuvante. A recidiva ocorreu em 20% dos casos. A mortalidade relacionada com o tumor foi de 7%.

Conclusões: As neoplasias das glândulas salivares minor são pouco frequentes, sendo as mais comuns o carcinoma adenoide quístico, o adenocarcinoma pleomórfico e o carcinoma mucoepidermóide. O tratamento cirúrgico é efetivo isoladamente em muitos casos. A mortalidade está relacionada com o estadio e com o tipo histológico do tumor. 

Referências

- Baddour HM Jr, Fedewa SA, Chen AY. Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of the Minor Salivary Gland. JAMA Otolaryngol Head Neck Surg. 2016 Jan 1;142(1):67-73.

- Cummings Otolaryngology, Head and Neck Surgery 6th edition.

- Barnes L, Eveson JW, Reichart P, et al. World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. Lyon: IARC Press; 2005. p 210.

- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

- Spiro RH, Thaler HT, Hickes WF, et al. (1991) The Importance of Clinical Staging of Minor Salivary Gland Carcinoma. Am J Surg 162:330–336

- Strick J, Kelly C, Soames V, et al. Malignant tumours of the minor salivary glands: a 20 year review. Br J Plast Surg. 2004;57(7): 624-631.

- Poorten V, Hunt J, Bradley P. Recent trends in the management of minor salivary gland carcinoma. Head and Neck. 2014 Mar;36(3):444-55.

- Buchner A, Merrell PW, Carpenter WM (2007) Relative frequency of intra-oral minor salivary gland tumors: a study of 380 cases from northern California and comparison to reports from other parts of the world. J Oral Pathol Med 36(4):207–214.

- Kruse A, Grätz K, Obwegeser J, et al.Malignant minor salivary gland tumors: a retrospective study of 27 cases. Oral Maxillofac Surg (2010) 14:203–209.

- Poorten V, Balm A, Hilgers F,et al. Stage as major long term outcome predictor in minor salivary gland carcinoma. Cancer 2000;89:1195–1204.

- Guzzo M, Locati L, Prott F, et al. Major and minor salivary gland tumors. Critical Reviews in oncology/Hamatology 74 (2010) 134-148.

- Horn-Ross PL,Morrow M, Ljung BM. Diet and the risk of salivary gland cancer. Am J Epidemiol 1997;146:171-6.

- Zheng W, Shu XO, Ji BT, et al. Diet and other risk factors for cancer of the salivary glands: a population-based case-control study. Int J Cancer 1996;194-8.

- Schneider AB, Lubin J, Ron E, et al. Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose–response relationships. Radiat Res 1998;149:625–30.

- Modan B, Chetrit A, Alfandary E, et al. Increased risk of salivar gland tumors after low-dose irradiation. Laryncope. 1998 Jul;108(7):1095-7.

- Dimery IW, Jones LA, Verjan RP, Raymond AK, Goepfert H, Hong WK (1987). Estrogen receptors in normal salivary gland and salivary gland carcinoma. Arch Otolaryngol Head Neck Surg 113: 1082- 1085.

- SerrainoD,BoschiniA,CarrieriP,etal.Cancerriskamongmenwith, or at risk of HIV infection in southern Europe. AIDS 2000;14:553–9.

- Dong C, Hemminki K. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanisms. Br J Cancer 2001;85:997–1005.

- Waldron CA, el Mofty SK, Gnepp DR. Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases. Oral Surg Oral Med Oral Pathol 1988;66:323–333.

- Van der Wal JE, Snow GB, van der Waal I. Histological reclassification of 101 intraoral salivary gland tumors (new WHO classification). J Clin Pathol 1992;45:834–835.

- Myers EN. Tumors of Minor Salivary Gland Origin. In: Salivary Gland disorders, Springer-Verlag Berlin Heidelberg 2007:pp 323-337.

- Fujita G, Sato S, Kishino M, et al. Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland. Mod Pathol 2011;24: 885–891.

- Bradley PJ (2004) Adenoid Cystic Carcinoma of the Head and Neck: A Review. Curr Opin Otolaryngol Head Neck Surg 12:127–130

- Pogodzinski MS, Sabri AN, Lewis JE, Olsen KD. Retrospective study and review of polymorphous low-grade adenocarcinoma. Laryngoscope 2006;116:2145–2149.

- Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carci- noma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck on- cology cooperative group. Head Neck 2004;26:681–693.

- Zeidan Y, Pekelis L, An Y, et al. Survival benefit for adjuvant radiation therapy in minor salivary gland cancers. Oral Oncology 51 (2015) 438–445

- Rosenberg L, Weissler M, Hayes DN, et al. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies. Head Neck 2012;34:872–876.

- Pederson A, Salama J, Haraf D, et al. Adjuvant chemoradiotherapy for locoregionally advances and high-risk salivary gland malignancies.

- Pederson W, Haraf J, Blair A, et al. Chemoreirradiation for recurrent salivary gland malignancies. Radiother Oncol 2010;95:308–311. Head & Neck Oncology 2011, 3:31.

- Lloyd, Shane, "A Prognostic Index for Predicting Lymph Node Metastasis in Minor Salivary Gland Cancer" (2009). Yale Medicine Thesis Digital Library. Paper 89.

- Garden A, Weber S, Ang K, et al. Postoperative radiation therapy for malignant tumors of minor salivary glands: outcome and patterns of failure. Cancer 1994;73:2563-9.

- Cianchetti M, Sandow P, Scarborough L, et al. Radiation therapy for Minor Salivary Gland Carcinoma. Laryngoscope 119:July 2009.

Publicado
2018-05-13
Como Citar
Candeias Deus, J., Menezes Peres, M., Hebe, A., Ferreira, L., Montalvão, P., & Magalhães, M. (2018). Neoplasias das glândulas salivares minor - Estudo retrospectivo. Revista Portuguesa De Otorrinolaringologia E Cirurgia Cérvico-Facial, 55(3), 147-153. Obtido de https://journalsporl.com/index.php/sporl/article/view/629
Secção
Artigo de Revisão